Physician profile
Shannon C Codispoti
NPI 1568752962
$1,075.02
in general payments reported to CMS, 2019-2025
9 companies · $88.76 in 2025
The $88.76 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $30.50 · 2021: $69.31 · 2022: $333 · 2023: $355 · 2024: $59.82 · 2025: $88.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $361.82 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Gilead Sciences, INC. | $306.57 | 2019-2025 | |
| Stryker Corporation | $175.00 | 2022 | |
| Viiv Healthcare Company | $121.50 | 2022 | |
| Novo Nordisk INC | $36.69 | 2022 | |
| Abbvie INC. | $27.36 | 2021 | |
| Ferring Pharmaceuticals INC. | $17.32 | 2019 | |
| Glaxosmithkline, LLC. | $15.07 | 2025 | Arexvy, Shingrix |
| Theratechnologies INC. | $13.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Codispoti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.